179 related articles for article (PubMed ID: 24218052)
1. Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998-2002.
Yao K; Winchester DJ; Czechura T; Huo D
Breast Cancer Res Treat; 2013 Dec; 142(3):465-76. PubMed ID: 24218052
[TBL] [Abstract][Full Text] [Related]
2. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
[TBL] [Abstract][Full Text] [Related]
3. Survival analysis of contralateral prophylactic mastectomy: a question of selection bias.
Kruper L; Kauffmann RM; Smith DD; Nelson RA
Ann Surg Oncol; 2014 Oct; 21(11):3448-56. PubMed ID: 25047478
[TBL] [Abstract][Full Text] [Related]
4. Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base.
Pesce CE; Liederbach E; Czechura T; Winchester DJ; Yao K
J Am Coll Surg; 2014 Jul; 219(1):19-28. PubMed ID: 24862886
[TBL] [Abstract][Full Text] [Related]
5. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
[TBL] [Abstract][Full Text] [Related]
6. Survival outcomes after contralateral prophylactic mastectomy: a decision analysis.
Portschy PR; Kuntz KM; Tuttle TM
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25031308
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.
Herrinton LJ; Barlow WE; Yu O; Geiger AM; Elmore JG; Barton MB; Harris EL; Rolnick S; Pardee R; Husson G; Macedo A; Fletcher SW
J Clin Oncol; 2005 Jul; 23(19):4275-86. PubMed ID: 15795415
[TBL] [Abstract][Full Text] [Related]
8. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
[TBL] [Abstract][Full Text] [Related]
9. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients.
Chung A; Huynh K; Lawrence C; Sim MS; Giuliano A
Ann Surg Oncol; 2012 Aug; 19(8):2600-6. PubMed ID: 22396004
[TBL] [Abstract][Full Text] [Related]
10. Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias.
Jatoi I; Parsons HM
Breast Cancer Res Treat; 2014 Nov; 148(2):389-96. PubMed ID: 25301088
[TBL] [Abstract][Full Text] [Related]
11. Operative risks associated with contralateral prophylactic mastectomy: a single institution experience.
Miller ME; Czechura T; Martz B; Hall ME; Pesce C; Jaskowiak N; Winchester DJ; Yao K
Ann Surg Oncol; 2013 Dec; 20(13):4113-20. PubMed ID: 23868655
[TBL] [Abstract][Full Text] [Related]
12. Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstruction.
Koslow S; Pharmer LA; Scott AM; Stempel M; Morrow M; Pusic AL; King TA
Ann Surg Oncol; 2013 Oct; 20(11):3422-9. PubMed ID: 23720070
[TBL] [Abstract][Full Text] [Related]
13. Incremental risk associated with contralateral prophylactic mastectomy and the effect on adjuvant therapy.
Eck DL; Perdikis G; Rawal B; Bagaria S; McLaughlin SA
Ann Surg Oncol; 2014 Oct; 21(10):3297-303. PubMed ID: 25047470
[TBL] [Abstract][Full Text] [Related]
14. Mortality impact of less-than-standard therapy in older breast cancer patients.
Yood MU; Owusu C; Buist DS; Geiger AM; Field TS; Thwin SS; Lash TL; Prout MN; Wei F; Quinn VP; Frost FJ; Silliman RA
J Am Coll Surg; 2008 Jan; 206(1):66-75. PubMed ID: 18155570
[TBL] [Abstract][Full Text] [Related]
15. Variation in Contralateral Prophylactic Mastectomy Rates According to Racial Groups in Young Women with Breast Cancer, 1998 to 2011: A Report from the National Cancer Data Base.
Grimmer L; Liederbach E; Velasco J; Pesce C; Wang CH; Yao K
J Am Coll Surg; 2015 Jul; 221(1):187-96. PubMed ID: 26047763
[TBL] [Abstract][Full Text] [Related]
16. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center.
Dragun AE; Pan J; Riley EC; Kruse B; Wilson MR; Rai S; Jain D
Am J Clin Oncol; 2013 Aug; 36(4):375-80. PubMed ID: 22643566
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.
Kuwajerwala NK; Dekhne NS; Pentiak PA; Fend D; Callahan RE; Amine M; Lucia V; Swartz J
Clin Breast Cancer; 2013 Aug; 13(4):287-91. PubMed ID: 23706482
[TBL] [Abstract][Full Text] [Related]
18. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution.
Jones NB; Wilson J; Kotur L; Stephens J; Farrar WB; Agnese DM
Ann Surg Oncol; 2009 Oct; 16(10):2691-6. PubMed ID: 19506956
[TBL] [Abstract][Full Text] [Related]
19. Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I-III unilateral breast cancer in the USA, 1998-2016.
Yang Y; Pan L; Shao Z
Breast Cancer Res Treat; 2021 Dec; 190(3):503-515. PubMed ID: 34554371
[TBL] [Abstract][Full Text] [Related]
20. Treatment trends and factors associated with survival in T1aN0 and T1bN0 breast cancer patients.
Kennedy T; Stewart AK; Bilimoria KY; Patel-Parekh L; Sener SF; Winchester DP
Ann Surg Oncol; 2007 Oct; 14(10):2918-27. PubMed ID: 17638060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
